Daniel Laheru is an Oncology physician affiliated with Bloomberg. OpenAlex indexes 644 publications with 36,665 citations (h-index 78); ClinicalTrials.gov lists 12 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Medical Oncology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
600 N Wolfe St
Baltimore, MD 212870005
Telephone
410-955-8964Registry record last updated 11 Feb 2013.
Clinical trials
- Feasibility and Efficacy of Neoadjuvant Cabozantinib Plus Nivolumab (CaboNivo) Followed by Definitive Resection for Patients With Locally Advanced Hepatocellular Carcinoma (HCC)
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- GVAX Pancreas Vaccine (With CY) in Combination With Nivolumab and SBRT for Patients With Borderline Resectable Pancreatic Cancer
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Neoantigen DNA Vaccine in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy
Sponsor: Washington University School of Medicine
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year20241 payment
- Merck Sharp & Dohme LLCProgram year20231 payment
- AstraZeneca Pharmaceuticals LPProgram year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
57.1%Platinum-based Drug53.3%Oxaliplatin100%Part B, office-administered≥15 patientsTopoisomerase Inhibitor2.2%Irinotecan100%Part B, office-administered≥15 patients+ 1 more class in this area
Metabolism & gastrointestinal
38.7%Other antiemetics29.4%Fosaprepitant100%Part B, office-administered≥16 patientsSerotonin-3 Receptor Antagonist5.2%Ondansetron hydrochloride100%Part B, office-administered≥21 patients+ 2 more classes in this area
Sensory organs
3.9%Corticosteroid3.9%Dexamethasone sodium phosphate99%Dexamethasone1%Part D + Part B≥21 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
3 NIH research awards on record, funded 2002–2009 per NIH RePORTER. The latest:
- Gene modified vaccine in combination with Ipilimumab for advanced pancreatic canc
Johns Hopkins University
FY2009$330,569R21CA126058 - Gene modified vaccine in combination with Ipilimumab for advanced pancreatic canc
Johns Hopkins University
FY2008$330,569R21CA126058 - STUDY OF CRS-100 ON ADULTS WITH CARCINOMA REFRACTORY AND LIVER METASTASES
Johns Hopkins University
FY2007$564M01RR000052
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Arturo Casadevall, MD
Bloomberg
Elizabeth Jaffee, MD
Bloomberg
William Sharfman, MD
Bloomberg
Cynthia Sears, MD
Bloomberg
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”